Genetic Signatures Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	16.08	15.9	9.77	16.94	35.42	28.28
Other Revenue	3.85	3.85	4	4.57	0.08	0.1
Revenue	19.94	19.75	13.77	21.51	35.5	28.38
Revenue Growth (YoY)	6.82%	43.47%	-36.00%	-39.39%	25.06%	105.43%
Cost of Revenue	9.81	9.25	7.91	11.83	13.6	11.25
Gross Profit	10.12	10.51	5.86	9.68	21.9	17.14
Selling, General & Admin	20.23	20.4	19.11	19.44	14.67	12.19
Other Operating Expenses	-0.13	2.34	3.09	3.31	2.58	1.99
Operating Expenses	22.33	25.13	24.19	24.28	18.87	15.61
Operating Income	-12.21	-14.63	-18.33	-14.59	3.03	1.53
Interest Expense	-0.07	-0.09	-0.04	-0	-0.02	-0.04
Interest & Investment Income	1.25	1.61	0.5	0.54	0.13	0.21
Currency Exchange Gain (Loss)	-	-	-	-	-0.09	-0.07
Other Non Operating Income (Expenses)	-0.05	-	-	-	0.01	0.13
EBT Excluding Unusual Items	-11.07	-13.11	-17.86	-14.05	3.06	1.76
Asset Writedown	-0.2	-7	-	-	-	-
Pretax Income	-11.27	-20.1	-17.86	-14.05	3.06	1.76
Net Income	-11.27	-20.1	-17.86	-14.05	3.06	1.76
Net Income to Common	-11.27	-20.1	-17.86	-14.05	3.06	1.76
Net Income Growth	-	-	-	-	74.43%	-
Shares Outstanding (Basic)	230	227	165	143	143	143
Shares Outstanding (Diluted)	230	227	165	143	145	146
Shares Change (YoY)	12.76%	37.18%	15.25%	-1.40%	-0.16%	14.76%
EPS (Basic)	-0.05	-0.09	-0.11	-0.10	0.02	0.01
EPS (Diluted)	-0.05	-0.09	-0.11	-0.10	0.02	0.01
EPS Growth	-	-	-	-	74.39%	-
Free Cash Flow	-10.67	-12.94	-12.1	-14.38	8.09	-0.46
Free Cash Flow Per Share	-0.05	-0.06	-0.07	-0.10	0.06	-0.00
Gross Margin	50.78%	53.19%	42.53%	45.01%	61.69%	60.38%
Operating Margin	-61.22%	-74.06%	-133.14%	-67.83%	8.54%	5.38%
Profit Margin	-56.53%	-101.78%	-129.74%	-65.32%	8.63%	6.19%
Free Cash Flow Margin	-53.52%	-65.52%	-87.88%	-66.86%	22.80%	-1.61%
EBITDA	-10.42	-12.67	-16.53	-13.07	4.3	2.56
EBITDA Margin	-52.27%	-64.14%	-120.05%	-60.74%	12.12%	9.02%
D&A For EBITDA	1.79	1.96	1.8	1.53	1.27	1.03
EBIT	-12.21	-14.63	-18.33	-14.59	3.03	1.53
EBIT Margin	-61.22%	-74.05%	-133.14%	-67.83%	8.54%	5.38%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.